Ricky Cain

830 total citations
15 papers, 655 citations indexed

About

Ricky Cain is a scholar working on Molecular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Ricky Cain has authored 15 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Medicine, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Ricky Cain's work include Antibiotic Resistance in Bacteria (9 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Ricky Cain is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Ricky Cain collaborates with scholars based in United Kingdom, United States and Latvia. Ricky Cain's co-authors include Colin W. G. Fishwick, Jürgen Brem, Christopher J. Schofield, James Spencer, M.A. McDonough, Samuel T. Cahill, Matthew B. Avison, Juan-Carlos Jiménez-Castellanos, I.J. Clifton and Christopher T. Lohans and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Ricky Cain

15 papers receiving 643 citations

Peers

Countries citing papers authored by Ricky Cain

Since Specialization

Citations

This map shows the geographic impact of Ricky Cain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricky Cain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricky Cain more than expected).

Fields of papers citing papers by Ricky Cain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricky Cain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricky Cain. The network helps show where Ricky Cain may publish in the future.

Co-authorship network of co-authors of Ricky Cain

This figure shows the co-authorship network connecting the top 25 collaborators of Ricky Cain. A scholar is included among the top collaborators of Ricky Cain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricky Cain. Ricky Cain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Anti-biofilm efficacy of a medieval treatment for bacterial infection requires the combination of multiple ingredients 2020 ·Scientific Reports ·(unknown), Blessing O. Anonye, Ricky Cain, John Moat, Catherine A. Ortori, Christina Lee, David A. Barrett, Christophe Corre, Freya Harrison	23
2	Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli 2020 ·Biomolecules ·Pauline A. Lang, (unknown), T.M. Leissing, Karina Calvopiña, Ricky Cain, Alen Krajnc, Tharindi Panduwawala, Jules Philippe, Colin W. G. Fishwick, Pēteris Trapencieris, Malcolm G. P. Page, Christopher J. Schofield, Jürgen Brem	27
3	Structure-Guided Enhancement of Selectivity of Chemical Probe Inhibitors Targeting Bacterial Seryl-tRNA Synthetase 2019 ·Journal of Medicinal Chemistry ·Ricky Cain, (unknown), (unknown), Dom Bellini, Colin W. G. Fishwick, Lloyd G. Czaplewski, David J. Scott, Gemma Harris, Christopher G. Dowson, Adrian J. Lloyd, David I. Roper	13
4	Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates 2019 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Samuel T. Cahill, Jonathan M. Tyrrell, Iva Navrátilová, Karina Calvopiña, Sean W. Robinson, Christopher T. Lohans, M.A. McDonough, Ricky Cain, Colin W. G. Fishwick, Matthew B. Avison, Timothy R. Walsh, Christopher J. Schofield, Jürgen Brem	25
5	Profiling interactions of vaborbactam with metallo-β-lactamases 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Ricky Cain, Jonathan M. Tyrrell, Philip Hinchliffe, Karina Calvopiña, Catherine L. Tooke, Emma Widlake, Christopher G. Dowson, James Spencer, Timothy R. Walsh, Christopher J. Schofield, Jürgen Brem	31
6	A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment 2017 ·Cancer Letters ·(unknown), Andrew J. Clark, Andrew Marsh, Daniel A. Mitchell, Ricky Cain, Colin W. G. Fishwick, Paul C. Taylor	32
7	Cyclic Boronates Inhibit All Classes of β-Lactamase. 2017 ·Oxford University Research Archive (ORA) (University of Oxford) ·Samuel T. Cahill, Ricky Cain, David Y. Wang, Christopher T. Lohans, David W. Wareham, Henry P. Oswin, (unknown), James Spencer, Colin W. G. Fishwick, M.A. McDonough, Christopher J. Schofield, Jürgen Brem	86
8	Structural/mechanistic insights into the efficacy of nonclassical β‐lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates 2017 ·Molecular Microbiology ·Karina Calvopiña, Philip Hinchliffe, Jürgen Brem, Kate J. Heesom, (unknown), Ricky Cain, Christopher T. Lohans, Colin W. G. Fishwick, Christopher J. Schofield, James Spencer, Matthew B. Avison	37
9	In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors 2017 ·Journal of Medicinal Chemistry ·Ricky Cain, Jürgen Brem, David Zollman, M.A. McDonough, (unknown), James Spencer, (unknown), Martine I. Abboud, Samuel T. Cahill, Sook Y. Lee, Peter J. McHugh, Christopher J. Schofield, Colin W. G. Fishwick	35
10	Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates 2016 ·Nature Communications ·Jürgen Brem, Ricky Cain, Samuel T. Cahill, M.A. McDonough, I.J. Clifton, Juan-Carlos Jiménez-Castellanos, Matthew B. Avison, James Spencer, Colin W. G. Fishwick, Christopher J. Schofield	195
11	Applications of structure-based design to antibacterial drug discovery 2014 ·Bioorganic Chemistry ·Ricky Cain, (unknown), Martin J. McPhillie, Katie J. Simmons, Colin W. G. Fishwick	14
12	Computational Methods to Identify New Antibacterial Targets 2014 ·Chemical Biology & Drug Design ·Martin J. McPhillie, Ricky Cain, (unknown), Colin W. G. Fishwick, Katie J. Simmons	19
13	Assay platform for clinically relevant metallo-beta-lactamases 2013 ·White Rose Research Online (University of Leeds, The University of Sheffield, University of York) ·(unknown), Jürgen Brem, (unknown), (unknown), Ricky Cain, Ankit Verma, (unknown), (unknown), Jonathan B. Spencer, (unknown)	6
14	Assay Platform for Clinically Relevant Metallo-β-lactamases 2013 ·Journal of Medicinal Chemistry ·Sander S. van Berkel, Jürgen Brem, Anna M. Rydzik, (unknown), Ricky Cain, Anil Kumar Verma, Raymond J. Owens, Colin W. G. Fishwick, James Spencer, Christopher J. Schofield	99
15	Effects of thioridazine on transmembrane potential and contractile characteristics of guinea pig hearts 1971 ·European Journal of Pharmacology ·Philip B. Hollander, Ricky Cain	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact